Klibanov A L, Maruyama K, Beckerleg A M, Torchilin V P, Huang L
Department of Biochemistry, University of Tennessee, Knoxville 37996-0840.
Biochim Biophys Acta. 1991 Feb 25;1062(2):142-8. doi: 10.1016/0005-2736(91)90385-l.
Dioleoyl-N-(monomethoxy polyethyleneglycol succinyl)-phosphatidylethanolamine (PEG-PE) (mol. wt. of PEG = 5000), an amphipathic polymer, can be incorporated into the liposome membrane and significantly prolong the blood circulation time of the liposome. As little as 3.7 mol% of PEG-PE in liposome resulted in maximal enhancement of liposome circulation time. However, this activity of PEG-PE was only seen with relatively small liposomes (d less than or equal to 200 nm); larger liposomes containing PEG-PE showed an unusually high level (approx. 35% injected dose) of accumulation in the spleen. We have tested whether the small, PEG-PE containing liposomes are suitable for immuno targeting by incorporating a lung-specific monoclonal antibody on the liposome surface. While another amphiphile, ganglioside GM1, which is well known for its activity to prolong the liposome circulation time, significantly enhanced the lung binding of the immunoliposomes, PEG-PE incorporation of immunoliposomes resulted in a low level of target binding. To test if the reduced target binding is due to a steric barrier effect of the surface PEG polymer, we have incorporated a small amount of N-biotinaminocaproylphosphatidylethanolamine into the PEG-PE containing liposomes and examined the liposome agglutination induced by the addition of streptavidin. As little as 0.72 mol% PEG-PE in these liposomes completely abolished agglutination. In contrast, incorporation of GM1 in liposomes only reduced the rate, but not the extent, of liposome agglutination. These results strongly support the hypothesis that PEG-PE prolongs liposome circulation time by providing a strong steric barrier which prevents close contact with another liposome or cell. Since GM1 provides only a weak steric barrier effect, its activity to prolong the liposome circulation time must involve another yet unknown mechanism.
二油酰基 - N -(单甲氧基聚乙二醇琥珀酰) - 磷脂酰乙醇胺(PEG - PE)(PEG的分子量 = 5000),一种两亲性聚合物,可掺入脂质体膜中并显著延长脂质体的血液循环时间。脂质体中仅3.7摩尔%的PEG - PE就能使脂质体循环时间得到最大程度的延长。然而,PEG - PE的这种活性仅在相对较小的脂质体(直径小于或等于200nm)中观察到;含有PEG - PE的较大脂质体在脾脏中显示出异常高水平(约35%注射剂量)的蓄积。我们通过在脂质体表面掺入肺特异性单克隆抗体来测试含PEG - PE的小脂质体是否适用于免疫靶向。虽然另一种两亲物神经节苷脂GM1以其延长脂质体循环时间的活性而闻名,它显著增强了免疫脂质体与肺的结合,但免疫脂质体中掺入PEG - PE导致靶标结合水平较低。为了测试靶标结合减少是否是由于表面PEG聚合物的空间位阻效应,我们在含PEG - PE的脂质体中掺入了少量的N - 生物素氨基己酰磷脂酰乙醇胺,并检查了添加链霉亲和素后诱导的脂质体凝集。这些脂质体中仅0.72摩尔%的PEG - PE就完全消除了凝集。相比之下,脂质体中掺入GM1仅降低了脂质体凝集的速率,但没有降低凝集程度。这些结果有力地支持了以下假设:PEG - PE通过提供强大的空间位阻屏障来防止与另一个脂质体或细胞紧密接触,从而延长脂质体的循环时间。由于GM1仅提供较弱的空间位阻效应,其延长脂质体循环时间的活性必定涉及另一种未知机制。